Page last updated: 2024-10-21

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Asthma, Bronchial

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with Asthma, Bronchial in 2 studies

1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one: structure given in first source; inhibits guanylyl cyclase
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one : A member of the class of oxadiazoloquinoxalines that is 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline substituted at position 1 by an oxo group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jonasson, S1
Hedenstierna, G1
Hjoberg, J1
Papapetropoulos, A1
Simoes, DC1
Xanthou, G1
Roussos, C1
Gratziou, C1

Other Studies

2 other studies available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Asthma, Bronchial

ArticleYear
Concomitant administration of nitric oxide and glucocorticoids improves protection against bronchoconstriction in a murine model of asthma.
    Journal of applied physiology (Bethesda, Md. : 1985), 2010, Volume: 109, Issue:2

    Topics: Administration, Inhalation; Animals; Anti-Asthmatic Agents; Asthma; Bronchial Provocation Tests; Bro

2010
Soluble guanylyl cyclase expression is reduced in allergic asthma.
    American journal of physiology. Lung cellular and molecular physiology, 2006, Volume: 290, Issue:1

    Topics: Animals; Asthma; Bronchial Hyperreactivity; Bronchoconstrictor Agents; Enzyme Inhibitors; Guanylate

2006